Diagnostics

Alveo Technologies Begins Shipping the First Point-of-Need™ Molecular Test for Avian Influenza in Poultry to the EU

Chris Cowen, seasoned global commercial executive in Life Sciences, joins as Chief Commercial Officer to drive future growth and scale…

3 weeks ago

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

New Non-Profit Organization Focuses on Early-Stage Sponsored Research and Venture Philanthropy to Advance Human Health and Well-being BOSTON, Oct. 31,…

3 weeks ago

New Treatments, Novel Research Drive Better Survival Rates for Canadians with Lung Cancer, Offering Hope to Thousands: Lung Health Foundation

Lung Cancer Awareness Month: Survivors Share Stories of Hope and Resilience Amid Revolutionary Medical BreakthroughsTORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE)…

3 weeks ago

MGI’s DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024

SHENZHEN, China, Oct. 30, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies…

3 weeks ago

Biosimulation Market to Hit USD 9.18 Billion by 2029 with 16.7% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 30, 2024 /PRNewswire/ -- The global biosimulation market is projected to reach USD 9.18 billion by 2029…

3 weeks ago

Thrive Global and Function Join Forces to Launch the First Personalized and Proactive Health Testing Benefit for Employees

By combining access to over 100 lab tests that track essential yet often overlooked health biomarkers with personalized expert coaching around…

3 weeks ago

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

STONY BROOK, NY / ACCESSWIRE / October 30, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),…

3 weeks ago

DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening

Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring BALTIMORE and PALO…

3 weeks ago

QuantalX Introduces a Breakthrough in the Diagnosis and Classification of Parkinson’s Disease

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- QuantalX Neuroscience, a leader in objective neurodiagnostic technology, announces a significant discovery in the…

3 weeks ago

PIECES TECHNOLOGIES AWARDED $2M FROM NATIONAL CANCER INSTITUTE, PART OF THE NATIONAL INSTITUTES OF HEALTH, TO ADVANCE USE OF CONVERSATIONAL AI TO IMPROVE THE CARE OF CANCER PATIENTS

Pieces will deploy new conversational AI at MetroHealth that will interact directly with cancer patients and leverage pioneering human oversight…

3 weeks ago